NASDAQ:PETS - Petmed Express Stock Price, Forecast & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PETS stock has increased by 2.5% and is now trading at $26.59. View which stocks have been mosted impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) announced its earnings results on Tuesday, January, 21st. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.30 by $0.04. The business earned $59.92 million during the quarter, compared to the consensus estimate of $61.31 million. Petmed Express had a return on equity of 19.91% and a net margin of 9.28%. The firm's revenue was down .2% on a year-over-year basis. During the same quarter last year, the business posted $0.38 earnings per share. View Petmed Express' earnings history.

Petmed Express declared a quarterly dividend on Tuesday, January 21st. Investors of record on Monday, February 3rd will be paid a dividend of $0.27 per share on Friday, February 14th. This represents a $1.08 annualized dividend and a yield of 4.06%. The ex-dividend date is Friday, January 31st. View Petmed Express' dividend history.

2 analysts have issued 12-month price objectives for Petmed Express' stock. Their forecasts range from $20.00 to $31.00. On average, they anticipate Petmed Express' stock price to reach $25.50 in the next year. This suggests that the stock has a possible downside of 4.1%. View analysts' price targets for Petmed Express.

News headlines about PETS stock have been trending somewhat negative on Sunday, according to InfoTrie. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Petmed Express earned a news sentiment score of -1.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news aboutPetmed Express.

Petmed Express saw a decrease in short interest in March. As of March 13th, there was short interest totaling 4,831,800 shares, a decrease of 8.1% from the February 27th total of 5,260,000 shares. Based on an average daily volume of 492,000 shares, the short-interest ratio is currently 9.8 days. Currently, 24.9% of the shares of the stock are short sold. View Petmed Express' Current Options Chain.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Tripadvisor (TRIP), Shutterfly (SFLY), 1-800-Flowers.Com (FLWS), Groupon (GRPN), Overstock.com (OSTK) and U.S. Auto Parts Network (PRTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), AT&T (T), Alibaba Group (BABA), NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), Netflix (NFLX), Advanced Micro Devices (AMD), Ford Motor (F) and Cisco Systems (CSCO).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (8.02%), State Street Corp (3.80%), Man Group plc (3.25%), Bank of New York Mellon Corp (1.97%), Personal Capital Advisors Corp (1.54%) and Geode Capital Management LLC (1.47%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni and Robert C Schweitzer. View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Newtyn Management LLC, UBS Group AG, Penserra Capital Management LLC, State Street Corp, Inlet Private Wealth LLC, Bank of New York Mellon Corp, and Cubist Systematic Strategies LLC. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, and Gian Fulgoni. View insider buying and selling activity for Petmed Express.

PETS stock was acquired by a variety of institutional investors in the last quarter, including Citigroup Inc., FMR LLC, Goldman Sachs Group Inc., Man Group plc, Personal Capital Advisors Corp, Oxford Asset Management LLP, Chicago Equity Partners LLC, and Cairn Investment Group Inc.. View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $26.59.

Petmed Express has a market capitalization of $536.32 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe. View additional information about Petmed Express.

The official website for Petmed Express is http://www.1800petmeds.com/.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.